Login / Signup

Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen.

Ming-Tsung HsiehWei-Lun ChangChung-Tai WuHsiao-Bai YangHsin-Yu KuoMeng-Ying LinHsiu-Chi ChengYu-Chin TsaiBor-Shyang Sheu
Published in: European journal of clinical pharmacology (2020)
Optimizing the MIC breakpoints of amoxicillin and tetracycline resistance better predicts the outcome of bismuth quadruple therapy. Further prospective studies using the revised MIC breakpoints to select antibiotics are warranted.
Keyphrases
  • helicobacter pylori
  • visible light
  • helicobacter pylori infection
  • oxide nanoparticles
  • bone marrow
  • cell therapy
  • replacement therapy